ArticleAntimicrobial agents and chemotherapy2025

Efficacy and safety of switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low-level viremia: a real-world 48-week extension study.

Meng-Wen He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.